Advancements in the Treatment Paradigm for Platinum-Resistant Ovarian Cancer
Speaker:
Robert Morris, MD
8:00 AM - 8:15 AM
Welcome
Speaker:
Michael Goodheart, MD
8:15 AM - 9:15 AM
Abstract Session I
Moderator:
Radhika Gogoi, MD, PhD
8:15 AM - 8:30 AM
A Peritoneal Implant for Monitoring of Ovarian Cancer (#001)
Speaker:
Aoibhín Sheedy, BME, MS, PhD
8:30 AM - 8:45 AM
Multimodal Models of HGSC Chemo-Response Prediction with Integration of Deep Learning Models of Imaging and Genomic Data (#002)
Speaker:
Katherine Sawaya, MD
8:45 AM - 9:00 AM
Identification of Ovarian Cancer with AI analysis of CT Scans (#003)
Speaker:
Katherine Sawaya, MD
9:00 AM - 9:15 AM
Identifying Mechanisms of Resistance in Recurrent Low Grade Serous Ovarian Cancer (#004)
Speaker:
Immaculate Edwin, BS, MS
9:15 AM - 10:00 AM
Posters & Exhibits Session I
Characterizing Platinum Resistance in Recurrent Endometrial Cancer: A Retrospective Cohort Study
Speaker:
Camilla Dagum, MD
Rates of Immune-related Adverse Events in Patients with Gynecologic Malignancies
Speaker:
Ellery Sarosi, MD
Evidence-Based Preoperative Imaging for Low-Grade Endometrioid Endometrial Cancer
Speaker:
Erin Johnson, DO
Trends Between ACOG Referral Criteria, Age and Surgical Histopathology
Speaker:
Rusha Bajpai, MD
Molecular Testing Completion and Timeliness of Endometrial Cancer Pathology Reports at an Urban Cancer Center
Speaker:
Chelsea Leipold, MD
Overall and Recurrence Free Survival of Inpatient Intraperitoneal Chemotherapy for Optimally Debulked Stage III Ovarian Cancer Patients
Speaker:
Adrienne Esposito, MD
Discovery of a Novel MXI1-NUTM2B Fusion in a Poorly Differentiated Ovarian Malignancy
Speaker:
Mohammed Elshafey, MD
Comparative Outcomes of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: Insights From a Single Institution
Speaker:
Ruth Bondurant, MD
10:00 AM - 11:00 AM
Abstract Session II
Moderator:
Andrea O'Shea, MD
10:00 AM - 10:15 AM
Glucagon-Like Peptide Receptor Agonists Are Associated with Superior 5-Year Overall Survival in Women with Endometrial Cancer (#005)
Speaker:
Kennedy Goodheart
10:15 AM - 10:30 AM
Improved Overall Survival With Combined Adjuvant Chemotherapy and Radiation in Clear Cell Carcinoma of the Uterus: A National Cancer Database Study (#006)
Speaker:
Adrienne Esposito, MD
10:30 AM - 10:45 AM
Robotic Uterine Transposition for Fertility Preservation in a Patient Undergoing Pelvic Radiation: A Case Report and Surgical Perspective (#007)
Speaker:
Jean-Marie Stephan, MD
10:45 AM - 11:00 AM
Hemostatic Agents and Early Postoperative Outcomes Following Minimally Invasive Hysterectomy in Gynecologic Oncology (#008)
Speaker:
Nicolette Codispoti, MD, MS, MPH
11:00 AM - 12:00 PM
Keynote Address
11:00 AM - 12:00 PM
Incidence and Outcome Disparities in High Grade Endometrial Cancers
Speaker:
Michele Cote, PhD, MPH
12:00 PM - 12:15 PM
Break
12:15 PM - 1:00 PM
Industry Sponsored Lunch Symposium
12:15 PM - 1:00 PM
Maintenance Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials
Speaker:
Amina Ahmed, MD
1:00 PM - 2:15 PM
Abstract Session III
Moderator:
Andrew Polio, MD
1:00 PM - 1:15 PM
Association of Social Vulnerability and Rurality on Cervical Dysplasia and Malignancy in Nebraska and Western Iowa (#009)
Speaker:
Claire Nissen, MD
1:15 PM - 1:30 PM
Associations Between Social Vulnerability, Rurality, and HPV Vaccination Practices in Patients With Vulvar Dysplasia and Malignancy in Nebraska and Western Iowa (#010)
Speaker:
Zoe Keese, BS
1:30 PM - 1:45 PM
Ethnic, Racial, and Geographic Disparities in Cervical Cancer Mortality Along the Us-Mexico Border From 1999 to 2020 (#011)
Speaker:
Abdelrahman Yousif, MD
1:45 PM - 2:00 PM
Cervical Cancer Disparities in the Heartland: Insurance Status and Treatment (#012)
Speaker:
Anna Morgan, MD
2:00 PM - 2:15 PM
Socioeconomic Health Disparities in Endometrial Cancer Diagnosis and Treatment Using Area Deprivation Index (#013)
Speaker:
Elizabeth Ingersent, BS
2:15 PM - 3:15 PM
Posters & Exhibits Session II
3:15 PM - 4:45 PM
Breakout Session
Moderator:
Michael Goodheart, MD
6:30 PM - 10:00 PM
Reception at the Old Capitol Museum
Saturday, September 20
7:00 AM - 7:45 AM
Industry Sponsored Breakfast Symposium
7:00 AM - 7:45 AM
Treatment Options for Appropriate Patients with Certain Types of Advanced Gynecologic Cancers
Speaker:
Robert Morris, MD
7:45 AM - 7:50 AM
Welcome to Day 2
Speaker:
Michael Goodheart, MD
7:50 AM - 8:50 AM
Abstract Session IV
Moderator:
Amanika Kumar, MD
7:50 AM - 8:05 AM
Quantifying Opportunities to Reduce High Grade Serous Ovarian Cancer via Opportunistic Salpingectomy (#014)
Speaker:
Kristin Tischer, MD
8:05 AM - 8:20 AM
The Impact of Environmental Factors and Social Determinants of Health on Molecular Alterations in a Single-Center Endometrial Cancer Cohort (#015)
Speaker:
Rabia Osman, MD
8:20 AM - 8:35 AM
Evaluating Patients’ Understanding of Their Gynecologic Cancer - Assessing an Etiology for Disparities in Clinical Trial Enrollment (#016)
Speaker:
Jisel Gomez, BS
8:35 AM - 8:50 AM
Readability of Gynecologic Cancer Patient Education Materials From NCI Designated Cancer Centers and Patient Directed Non-Profit Organizations (#017)
Speaker:
Bridget Dillon, MD
8:50 AM - 10:00 AM
Posters & Exhibits Session III
10:00 AM - 11:00 AM
Keynote Lecture
10:00 AM - 11:00 AM
Partnering for Progress: Collaborating with Patient Advocates to Advance Gynecologic Oncology Research
Speaker:
Kathleen Gavin, MPH
11:00 AM - 11:45 AM
Marketplace of Ideas
Moderator:
Andrea O'Shea, MD
11:00 AM - 11:15 AM
Prospective Analysis of Circulating Tumor DNA Levels Post-Surgery and Post-Chemotherapy for Early-Stage High Grade Ovarian Cancer (#026)
Speaker:
Sarah McDonald, MD
11:15 AM - 11:30 AM
Endometrial Cancer Surgical Interactive Care Plan (#027)
Speaker:
Leah Grcevich, DO
11:30 AM - 11:45 AM
Reducing Distress: A Video-Based Intervention for Cervical Cancer Radiation Therapy (#028)